WHO ICTRP trial

Doxycycline cures non-infective-nonmalignant lung lessions.

CTRI/2013/10/004080 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2013/10/004080
Public title Doxycycline cures non-infective-nonmalignant lung lessions.
Scientific title Role of doxycycline in treating different tissue lesions and thickening of lung and pleura: a pilot case based observation with different types of lesions.
Primary sponsor Dr Parthasarathi Bhattacharyya
Secondary sponsors Institute of Pulmocare and Research
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: null- with different lung lesions
Interventions Intervention1: Doxycycline: 100 mg BD for body weight over 45kg and 100 mg OD for body weight less than 45kg. route of administration- Orally. Intervention2: Doxycycline 100 mg: Doxycycline 100 mg BD for body weight over 45 kg and 100 mg OD…
Registration date Oct 18, 2013
Target size 30
Secondary IDs IPCR/LTL/001
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations